|
US3843662A
(en)
|
1971-12-09 |
1974-10-22 |
Pfizer |
2-halo-5-(substituted piperidino sulfonyl)benzoic acids
|
|
AU1508183A
(en)
|
1982-06-04 |
1983-12-08 |
Beecham Group Plc |
Benzamide and anilide derivatives of 8-azabicyclo-(3.2.1)- -octane
|
|
EP0135545A1
(en)
|
1983-02-19 |
1985-04-03 |
Beecham Group Plc |
Azabicycloalkyl benzamide and anilide derivatives
|
|
JPS62142164A
(ja)
|
1985-12-13 |
1987-06-25 |
Ishihara Sangyo Kaisha Ltd |
４，５−ジクロロイミダゾ−ル系化合物及びそれらを含有する有害生物防除剤
|
|
IN164880B
(es)
|
1986-01-30 |
1989-06-24 |
Ishihara Sangyo Kaisha |
|
|
US5272167A
(en)
|
1986-12-10 |
1993-12-21 |
Schering Corporation |
Pharmaceutically active compounds
|
|
GB8904174D0
(en)
|
1989-02-23 |
1989-04-05 |
British Bio Technology |
Compounds
|
|
US4962101A
(en)
|
1989-08-21 |
1990-10-09 |
Merck & Co., Inc. |
2-(Heterocyclylalkyl)phenyl carbapenem antibacterial agents
|
|
GB9023082D0
(en)
|
1990-10-24 |
1990-12-05 |
Schering Agrochemicals Ltd |
Fungicides
|
|
GB9109557D0
(en)
|
1991-05-02 |
1991-06-26 |
Wellcome Found |
Chemical compounds
|
|
US5308826A
(en)
|
1993-04-22 |
1994-05-03 |
Zeneca Limited |
Herbicidal 4-substituted pyridyl-3-carbinols
|
|
US5795907A
(en)
|
1994-05-27 |
1998-08-18 |
James Black Foundation Limited |
Gastin and CCK receptor ligands
|
|
WO1995032949A1
(en)
|
1994-05-27 |
1995-12-07 |
James Black Foundation Limited |
Gastrin and cck antagonists
|
|
US5763618A
(en)
|
1995-05-12 |
1998-06-09 |
Konica Corporation |
Manufacturing method of sulfides
|
|
US5723411A
(en)
|
1995-10-31 |
1998-03-03 |
E. I. Du Pont De Nemours And Company |
Herbicidal pyridazinones
|
|
DE19540995A1
(de)
|
1995-11-03 |
1997-05-07 |
Hoechst Ag |
Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
|
GB9612884D0
(en)
|
1996-06-20 |
1996-08-21 |
Smithkline Beecham Plc |
Novel compounds
|
|
WO1997049695A1
(en)
|
1996-06-25 |
1997-12-31 |
Smithkline Beecham P.L.C. |
Sulfonamide derivatives as 5ht7 receptor antagonists
|
|
AU5127098A
(en)
|
1996-11-29 |
1998-06-22 |
Smithkline Beecham Plc |
Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
|
|
US5939423A
(en)
|
1997-04-16 |
1999-08-17 |
Sciclone Pharmaceuticals, Inc. |
Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir
|
|
US5919970A
(en)
|
1997-04-24 |
1999-07-06 |
Allergan Sales, Inc. |
Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
|
|
US5994396A
(en)
|
1997-08-18 |
1999-11-30 |
Centaur Pharmaceuticals, Inc. |
Furansulfonic acid derivatives and pharmaceutical compositions containing the same
|
|
AU759255B2
(en)
|
1998-01-29 |
2003-04-10 |
Amgen, Inc. |
PPAR-gamma modulators
|
|
BR9909666A
(pt)
|
1998-03-26 |
2001-09-11 |
Japan Tobacco Inc |
Derivados de amida e antagonistas de nociceptina
|
|
US6251893B1
(en)
|
1998-06-15 |
2001-06-26 |
Nps Allelix Corp. |
Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
|
|
CZ300366B6
(cs)
|
1999-01-15 |
2009-05-06 |
Nycomed Gmbh |
Fenylfenanthridinová sloucenina, farmaceutický prostredek s jejím obsahem a její použití
|
|
KR20020015376A
(ko)
|
1999-07-16 |
2002-02-27 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
Ｍｅｋ 억제제를 사용한 만성 통증의 치료 방법
|
|
JP2003506406A
(ja)
|
1999-08-10 |
2003-02-18 |
ザ・チャンセラー・マスターズ・アンド・スカラーズ・オブ・ザ・ユニバーシティ・オブ・オックスフォード |
長鎖ｎ−アルキル化合物およびそのオキサ誘導体
|
|
CA2385592C
(en)
|
1999-09-17 |
2011-01-11 |
Bing-Yan Zhu |
Benzamides and related inhibitors of factor xa
|
|
AU2018301A
(en)
|
1999-12-28 |
2001-07-24 |
Pfizer Products Inc. |
Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
|
|
WO2001055121A1
(en)
|
2000-01-28 |
2001-08-02 |
Kaken Pharmaceutical Co., Ltd. |
Azepine derivatives
|
|
US6511980B2
(en)
|
2000-05-05 |
2003-01-28 |
Ortho Mcneil Pharmaceutical, Inc. |
Substituted diamine derivatives useful as motilin antagonists
|
|
EP1193268A1
(en)
|
2000-09-27 |
2002-04-03 |
Applied Research Systems ARS Holding N.V. |
Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases
|
|
WO2002051410A2
(en)
|
2000-12-22 |
2002-07-04 |
Akzo Nobel N.V. |
Phenylthiazole and thiazoline derivatives and their use as antiparasitics
|
|
DE60115501T2
(de)
|
2000-12-27 |
2006-07-13 |
Dainippon Sumitomo Pharma Co., Ltd. |
Neue Carbapenemverbindungen, Arzneimittel und antibakterielles Mittel, das diese enthält, und deren Verwendungen
|
|
AU2002248418A1
(en)
|
2001-02-09 |
2002-08-28 |
Massachusetts Institute Of Technology |
Methods of identifying agents that mediate polypeptide aggregation
|
|
US6650463B2
(en)
|
2001-03-13 |
2003-11-18 |
Seiko Epson Corporation |
Electrophoretic display device
|
|
WO2003007955A2
(en)
|
2001-07-20 |
2003-01-30 |
Cancer Research Technology Limited |
Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
|
|
DE10136043A1
(de)
|
2001-07-25 |
2003-02-13 |
Degussa |
Verfahren zur Herstellung von modifiziertem Ruß
|
|
US6956035B2
(en)
|
2001-08-31 |
2005-10-18 |
Inotek Pharmaceuticals Corporation |
Isoquinoline derivatives and methods of use thereof
|
|
EP1448560B1
(en)
|
2001-11-20 |
2005-06-15 |
Eli Lilly And Company |
3-SUBSTITUTED OXINDOLE beta 3 AGONISTS
|
|
SE0201635D0
(sv)
|
2002-05-30 |
2002-05-30 |
Astrazeneca Ab |
Novel compounds
|
|
CN1658849A
(zh)
|
2002-06-05 |
2005-08-24 |
株式会社医药分子设计研究所 |
Ap－1和nfat活化抑制剂
|
|
EP1531815B1
(en)
|
2002-06-27 |
2014-09-24 |
Novo Nordisk A/S |
Glucokinase activators
|
|
RU2340605C2
(ru)
|
2002-06-27 |
2008-12-10 |
Ново Нордиск А/С |
Арилкарбонильные производные в качестве терапевтических средств
|
|
WO2004011427A2
(en)
|
2002-07-31 |
2004-02-05 |
Smithkline Beecham Corporation |
Substituted benzanilides as modulators of the ccr5 receptor
|
|
WO2004010943A2
(en)
|
2002-07-31 |
2004-02-05 |
Smithkline Beecham Corporation |
Substituted benzanilides as modulators of the ccr5 receptor
|
|
US7186735B2
(en)
|
2002-08-07 |
2007-03-06 |
Sanofi-Aventis Deutschland Gmbh |
Acylated arylcycloalkylamines and their use as pharmaceuticals
|
|
US7338956B2
(en)
|
2002-08-07 |
2008-03-04 |
Sanofi-Aventis Deutschland Gmbh |
Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
|
|
JP4399862B2
(ja)
|
2002-08-09 |
2010-01-20 |
味の素株式会社 |
腸疾患および内臓痛の治療薬
|
|
CN1694704A
(zh)
|
2002-09-06 |
2005-11-09 |
詹森药业有限公司 |
（1h－苯并咪唑－2－基）－（哌嗪基）－甲酮衍生物及其相关化合物作为组胺h4受体拮抗剂用于治疗炎性和过敏性疾病
|
|
SE0202838D0
(sv)
|
2002-09-24 |
2002-09-24 |
Astrazeneca Ab |
Chemical compounds
|
|
US7378525B2
(en)
|
2002-12-23 |
2008-05-27 |
Millennium Pharmaceuticals, Inc. |
CCR8 inhibitors
|
|
US7320989B2
(en)
|
2003-02-28 |
2008-01-22 |
Encysive Pharmaceuticals, Inc. |
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
|
|
US7595322B2
(en)
|
2003-03-27 |
2009-09-29 |
Cytokinetics, Inc. |
Heterocyclic sulfonamides as modulators of cardiac sarcomeres
|
|
WO2004099192A2
(en)
|
2003-04-30 |
2004-11-18 |
The Institutes Of Pharmaceutical Discovery, Llc |
Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
|
|
EP1620094A4
(en)
|
2003-05-06 |
2010-04-28 |
Glaxosmithkline Llc |
NEW CHEMICAL COMPOUNDS
|
|
US7368457B2
(en)
|
2003-05-13 |
2008-05-06 |
Schering Corporation |
Bridged N-arylsulfonylpiperidines as gamma-secretase inhibitors
|
|
WO2005007621A2
(en)
|
2003-05-30 |
2005-01-27 |
Rigel Pharmaceuticals, Inc. |
Ubiquitin ligase inhibitors
|
|
US20110275630A1
(en)
|
2003-06-02 |
2011-11-10 |
Abbott Laboratories |
Isoindolinone kinase inhibitors
|
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
|
GB0319151D0
(en)
|
2003-08-14 |
2003-09-17 |
Glaxo Group Ltd |
Novel compounds
|
|
US8084457B2
(en)
|
2003-09-15 |
2011-12-27 |
Lead Discovery Center Gmbh |
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
US7498050B2
(en)
|
2003-12-15 |
2009-03-03 |
Kraft Foods Global Brands Llc |
Edible spread composition and packaged product
|
|
DE102004009238A1
(de)
|
2004-02-26 |
2005-09-08 |
Merck Patent Gmbh |
Arylamid-Derivate
|
|
WO2005087217A1
(en)
|
2004-03-05 |
2005-09-22 |
The General Hospital Corporation |
Compositions and methods for modulating interaction between polypeptides
|
|
WO2005105785A2
(en)
|
2004-05-04 |
2005-11-10 |
Novo Nordisk A/S |
Indole derivatives for treatment of obesity
|
|
US20090105218A1
(en)
|
2004-05-29 |
2009-04-23 |
7Tm Pharma A/S |
CRTH2 Receptor Ligands For Therapeutic Use
|
|
WO2006002133A1
(en)
|
2004-06-22 |
2006-01-05 |
Schering Corporation |
Cannabinoid receptor ligands
|
|
AU2005278959A1
(en)
|
2004-08-31 |
2006-03-09 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as B-Raf inhibitors
|
|
DE102004042441A1
(de)
|
2004-08-31 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Mit Aminosäuren substituierte Hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
WO2006049835A2
(en)
|
2004-10-19 |
2006-05-11 |
Novartis Vaccines And Diagnostics Inc. |
Indole and benzimidazole derivatives
|
|
TW200628463A
(en)
|
2004-11-10 |
2006-08-16 |
Synta Pharmaceuticals Corp |
Heteroaryl compounds
|
|
US20060122236A1
(en)
|
2004-12-06 |
2006-06-08 |
Wood Michael R |
Substituted biaryl-carboxylate derivatives
|
|
EP1831198B1
(en)
|
2004-12-22 |
2009-04-08 |
AstraZeneca AB |
Pyridine carboxamide derivatives for use as anticancer agents
|
|
AR053992A1
(es)
|
2004-12-22 |
2007-05-30 |
Astrazeneca Ab |
Compuestos quimicos con actividad anticancerosa, un procedimiento para su preparacion, su uso en la preparacion de medicamentos y composicion farmaceutica.
|
|
FI117653B
(fi)
|
2005-02-21 |
2006-12-29 |
Eigenor Oy |
Menetelmä ja laitteisto liikkuvien kohteiden havaitsemiseksi tutkalla
|
|
GB0510141D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
|
US7790726B2
(en)
|
2005-08-16 |
2010-09-07 |
Chemocentryx, Inc. |
Monocyclic and bicyclic compounds and methods of use
|
|
AU2006290442B2
(en)
|
2005-09-16 |
2010-07-29 |
Arrow Therapeutics Limited |
Biphenyl derivatives and their use in treating hepatitis C
|
|
AU2006331770A1
(en)
|
2005-12-21 |
2007-07-05 |
Schering Corporation |
Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and H3 receptor antagonist/inverse agonist
|
|
US20090018118A1
(en)
|
2005-12-29 |
2009-01-15 |
Uros Urleb |
Heterocyclic compounds
|
|
EP2019830A4
(en)
|
2006-05-04 |
2011-01-19 |
Inst Hepatitis & Virus Res |
INHIBITORS OF THE SECRETION OF HEPATITIS B VIRUS ANTIGENS FOR THE TREATMENT OF A CHRONIC HEPATITIS VIRUS
|
|
US8153803B2
(en)
|
2006-07-18 |
2012-04-10 |
The General Hospital Corporation |
Compositions and methods for modulating sirtuin activity
|
|
US20080021063A1
(en)
|
2006-07-18 |
2008-01-24 |
Kazantsev Aleksey G |
Compositions and methods for modulating sirtuin activity
|
|
FR2903985B1
(fr)
|
2006-07-24 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
|
FR2904316B1
(fr)
|
2006-07-31 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
|
|
WO2008022171A1
(en)
|
2006-08-17 |
2008-02-21 |
Boehringer Ingelheim International Gmbh |
Methods of using aryl sulfonyl compounds effective as soluble epoxide hydrolase inhibitors
|
|
WO2008076270A2
(en)
|
2006-12-13 |
2008-06-26 |
Temple University-Of The Commonwealth System Of Higher Education |
Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
|
|
US20100022517A1
(en)
|
2006-12-18 |
2010-01-28 |
Richards Lori A |
Ophthalmic formulation of rho kinase inhibitor compound
|
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
|
FR2910473B1
(fr)
|
2006-12-26 |
2009-02-13 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
|
|
JP2008179621A
(ja)
|
2006-12-28 |
2008-08-07 |
Taisho Pharmaceutical Co Ltd |
含窒素飽和複素環化合物
|
|
JP2008184403A
(ja)
|
2007-01-29 |
2008-08-14 |
Japan Health Science Foundation |
新規ｃ型肝炎ウイルス阻害剤
|
|
AU2008225766B2
(en)
|
2007-03-15 |
2012-06-07 |
Novartis Ag |
Organic compounds and their uses
|
|
US8097728B2
(en)
|
2007-04-30 |
2012-01-17 |
Philadelphia Health & Education Corporation |
Iminosugar compounds with antiflavirus activity
|
|
JP5160637B2
(ja)
|
2007-05-04 |
2013-03-13 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
ｃ−ｋｉｔおよびＰＤＧＦＲキナーゼインヒビターとしての化合物および組成物
|
|
WO2008154819A1
(fr)
|
2007-06-18 |
2008-12-24 |
Zhang, Zhongneng |
Thiazolyl-dihydropyrimidines à substitution carbéthoxy
|
|
EP2182935A1
(en)
|
2007-08-02 |
2010-05-12 |
F. Hoffmann-Roche AG |
The use of benzamide derivatives for the treatment of cns disorders
|
|
CN101429166B
(zh)
|
2007-11-07 |
2013-08-21 |
上海特化医药科技有限公司 |
喹唑啉酮衍生物及其制备方法和用途
|
|
JP2011507910A
(ja)
|
2007-12-21 |
2011-03-10 |
ユニバーシティー オブ ロチェスター |
真核生物の寿命を変更するための方法
|
|
FR2926555B1
(fr)
|
2008-01-22 |
2010-02-19 |
Sanofi Aventis |
Derives bicycliques de carboxamides azabicycliques, leur preparation et leur application en therapeutique
|
|
FR2926556B1
(fr)
|
2008-01-22 |
2010-02-19 |
Sanofi Aventis |
Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
|
|
FR2926554B1
(fr)
|
2008-01-22 |
2010-03-12 |
Sanofi Aventis |
Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
|
|
FR2926553B1
(fr)
|
2008-01-23 |
2010-02-19 |
Sanofi Aventis |
Derives d'indole-2-carboxamides et d'azaindole-2- carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique
|
|
WO2009146013A1
(en)
|
2008-03-31 |
2009-12-03 |
Georgetown University |
Myosin light chain phosphatase inhibitors
|
|
CN102015638A
(zh)
|
2008-04-24 |
2011-04-13 |
万有制药株式会社 |
以芳基磺酰基衍生物作为有效成分的长链脂肪酸延长酶抑制剂
|
|
US8207195B2
(en)
|
2008-06-26 |
2012-06-26 |
Inspire Pharmaceuticals, Inc. |
Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds
|
|
US8410147B2
(en)
|
2008-06-26 |
2013-04-02 |
Inspire Pharmaceuticals, Inc. |
Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds
|
|
US20090325959A1
(en)
|
2008-06-26 |
2009-12-31 |
Vittitow Jason L |
Method for treating ophthalmic diseases using rho kinase inhibitor compounds
|
|
US20100008968A1
(en)
|
2008-06-26 |
2010-01-14 |
Lampe John W |
Method for treating cardiovascular diseases using rho kinase inhibitor compounds
|
|
US8299096B2
(en)
|
2008-06-26 |
2012-10-30 |
Inspire Pharmaceuticals, Inc. |
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
|
US20090325960A1
(en)
|
2008-06-26 |
2009-12-31 |
Fulcher Emilee H |
Method for treating inflammatory diseases using rho kinase inhibitor compounds
|
|
CA2735392A1
(en)
|
2008-08-15 |
2010-02-18 |
F. Hoffmann-La Roche Ag |
Bi-aryl aminotetralines
|
|
US9040488B2
(en)
|
2008-09-02 |
2015-05-26 |
Baruch S. Blumberg Institute |
Imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity
|
|
WO2010043592A1
(en)
|
2008-10-15 |
2010-04-22 |
Revotar Biopharmaceuticals Ag |
Lipase inhibitors for use for the treatment of obesity
|
|
EP2400969A4
(en)
|
2008-12-04 |
2012-05-16 |
Inspire Pharmaceuticals Inc |
METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITORY COMPOUNDS
|
|
CA2748174A1
(en)
|
2008-12-30 |
2010-07-08 |
Arqule, Inc. |
Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds
|
|
WO2010088000A2
(en)
|
2009-02-02 |
2010-08-05 |
Angion Biomedica Corp. |
Antifibrotic compounds and uses thereof
|
|
WO2010123139A1
(ja)
|
2009-04-24 |
2010-10-28 |
持田製薬株式会社 |
スルファモイル基を有するアリールカルボキサミド誘導体
|
|
CN102469788A
(zh)
|
2009-06-30 |
2012-05-23 |
西佳技术公司 |
登革病毒感染的治疗和预防
|
|
US8822700B2
(en)
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8703938B2
(en)
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
WO2011035143A2
(en)
|
2009-09-17 |
2011-03-24 |
The Regents Of The University Of Michigan |
Methods and compositions for inhibiting rho-mediated diseases and conditions
|
|
WO2011058766A1
(en)
|
2009-11-16 |
2011-05-19 |
Raqualia Pharma Inc. |
Aryl carboxamide derivatives as ttx-s blockers
|
|
CN102093320B
(zh)
|
2009-12-09 |
2013-08-28 |
扬子江药业集团上海海尼药业有限公司 |
一种可溶性环氧化物水解酶抑制剂
|
|
WO2011088015A1
(en)
|
2010-01-15 |
2011-07-21 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
|
WO2011088561A1
(en)
|
2010-01-20 |
2011-07-28 |
University Of Manitoba |
Anti-viral compounds and compositions
|
|
WO2011109237A2
(en)
|
2010-03-02 |
2011-09-09 |
Emory University |
Uses of noscapine and derivatives in subjects diagnosed with fap
|
|
JP2013522192A
(ja)
|
2010-03-11 |
2013-06-13 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｃ型肝炎の処置のための化合物
|
|
JP2013523766A
(ja)
|
2010-03-31 |
2013-06-17 |
グラクソ グループ リミテッド |
キナーゼ阻害剤としてのイミダゾリル‐イミダゾール
|
|
PH12012502194A1
(en)
|
2010-05-07 |
2014-09-05 |
Glaxosmithkline Llc |
Indoles
|
|
WO2011155898A1
(en)
|
2010-06-11 |
2011-12-15 |
Wadell Goeran |
New antiviral compounds
|
|
US20130142827A1
(en)
|
2010-06-25 |
2013-06-06 |
Philadelphia Health & Education Corporation D/B/A |
Induction of immune response
|
|
WO2012012282A1
(en)
|
2010-07-19 |
2012-01-26 |
Inspire Pharmaceuticals, Inc. |
Bifunctional rho kinase inhibitor compounds, composition and use
|
|
JP2013536178A
(ja)
|
2010-07-26 |
2013-09-19 |
ニューロセラピューティクス ファーマ， インコーポレイテッド |
アリールスルホンアミド誘導体、組成物、および使用方法
|
|
BR112013001015A2
(pt)
|
2010-07-27 |
2016-05-24 |
Inspire Pharmaceuticals Inc |
método por tratar doenças oftálmicas que usam compostos de inibidor de cinase em formas de prodrug
|
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
|
WO2012033956A1
(en)
|
2010-09-08 |
2012-03-15 |
Mithridion, Inc. |
Cognition enhancing compounds and compositions, methods of making, and methods of treating
|
|
WO2012047856A2
(en)
|
2010-10-04 |
2012-04-12 |
Institute For Hepatitis And Virus Research |
Novel inhibitors of secretion of hepatitis b virus antigens
|
|
GB201017345D0
(en)
|
2010-10-14 |
2010-11-24 |
Proximagen Ltd |
Receptor antagonists
|
|
EP2646439B1
(en)
|
2010-12-02 |
2016-05-25 |
Bristol-Myers Squibb Company |
Alkyl amides as hiv attachment inhibitors
|
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
|
GB201103419D0
(es)
|
2011-02-28 |
2011-04-13 |
Univ Aberdeen |
|
|
PH12013502033A1
(en)
|
2011-04-08 |
2014-01-06 |
Janssen Sciences Ireland Uc |
Pyrimidine derivatives for the treatment of viral infections
|
|
US8889716B2
(en)
|
2011-05-10 |
2014-11-18 |
Chdi Foundation, Inc. |
Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
EP2726459B1
(en)
|
2011-07-01 |
2019-09-11 |
Baruch S. Blumberg Institute |
Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
|
|
CN106957282B
(zh)
|
2011-12-21 |
2019-08-30 |
诺维拉治疗公司 |
B型肝炎抗病毒剂
|
|
ES2581489T3
(es)
|
2012-01-06 |
2016-09-06 |
Janssen Sciences Ireland Uc |
1,4-dihidropirimidinas 4,4-disustituidas y el uso de las mismas como medicamentos para el tratamiento de la hepatitis B
|
|
JP6134338B2
(ja)
|
2012-02-29 |
2017-05-24 |
バルーク エス．ブルームバーグ インスティテュート |
Ｂ型肝炎ウイルス共有結合閉環状ｄｎａ形成の阻害剤およびそれらの使用方法
|
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
|
WO2013181584A2
(en)
|
2012-06-01 |
2013-12-05 |
Guo, Ju-Tao |
Modulation of hepatitis b virus cccdna transcription
|
|
JO3300B1
(ar)
|
2012-06-06 |
2018-09-16 |
Novartis Ag |
مركبات وتركيبات لتعديل نشاط egfr
|
|
TW201408652A
(zh)
|
2012-07-11 |
2014-03-01 |
Hoffmann La Roche |
作爲ＲＯＲｃ調節劑之芳基磺內醯胺衍生物
|
|
AR092270A1
(es)
|
2012-08-28 |
2015-04-08 |
Janssen R&D Ireland |
Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
|
|
UA115069C2
(uk)
|
2012-08-28 |
2017-09-11 |
ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі |
Конденсовані біциклічні похідні сульфамоїлу та їх застосування як лікарських препаратів для лікування гепатиту b
|
|
EP2892893B2
(en)
|
2012-09-10 |
2019-10-16 |
F.Hoffmann-La Roche Ag |
6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
|
SG11201504740UA
(en)
|
2012-12-27 |
2015-07-30 |
Univ Drexel |
Novel antiviral agents against hbv infection
|
|
ES2628953T3
(es)
|
2013-02-28 |
2017-08-04 |
Janssen Sciences Ireland Uc |
Sulfamoilarilamidas y el uso de las mismas como medicamentos para el tratamiento de la hepatitis B
|
|
BR112015020545A2
(pt)
|
2013-02-28 |
2017-07-18 |
Eisai R&D Man Co Ltd |
derivado de tetraidroimidazo[1,5-d][1,4]oxazepina
|
|
WO2014165128A2
(en)
|
2013-03-12 |
2014-10-09 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
|
US9944658B2
(en)
|
2013-03-14 |
2018-04-17 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
MX353412B
(es)
|
2013-04-03 |
2018-01-10 |
Janssen Sciences Ireland Uc |
Derivados de n-fenil-carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b.
|
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
|
JP6441315B2
(ja)
|
2013-05-17 |
2018-12-19 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
スルファモイルチオフェンアミド誘導体およびｂ型肝炎を治療するための医薬品としてのその使用
|
|
LT3004090T
(lt)
|
2013-05-28 |
2018-01-10 |
Astrazeneca Ab |
Cheminiai junginiai
|
|
US9688681B2
(en)
|
2013-05-28 |
2017-06-27 |
Bayer Cropscience Aktiengesellschaft |
Heterocyclic compounds as pest control agents
|
|
WO2014198880A1
(en)
|
2013-06-14 |
2014-12-18 |
Ferrer Internacional, S.A. |
2-(2-aminophenoxy)-3-chloronaphthalene-1,4-dione compounds having orexin 2 receptor agonist activity
|
|
PL3024819T3
(pl)
|
2013-07-25 |
2018-08-31 |
Janssen Sciences Ireland Uc |
Pochodne piroloamidowe podstawione glioksamidem i ich zastosowanie jako leków do leczenia wirusowego zapalenia wątroby typu B
|
|
WO2015055764A1
(en)
|
2013-10-18 |
2015-04-23 |
Syngenta Participations Ag |
3-methanimidamid-pyridine derivatives as fungicides
|
|
WO2015057945A1
(en)
|
2013-10-18 |
2015-04-23 |
Indiana University Research And Technology Corporation |
Hepatitis b viral assembly effectors
|
|
SG11201602748XA
(en)
|
2013-10-23 |
2016-05-30 |
Janssen Sciences Ireland Uc |
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
|
US9115113B2
(en)
|
2013-11-14 |
2015-08-25 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
|
JO3466B1
(ar)
|
2013-12-20 |
2020-07-05 |
Takeda Pharmaceuticals Co |
مواد ضابطة لتترا هيدرو بيريدوبيرازينات من gpr6
|
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
|
DK3099296T3
(en)
|
2014-01-31 |
2019-04-15 |
Cognition Therapeutics Inc |
ISO-INDOLINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
|
|
KR20160128305A
(ko)
|
2014-02-05 |
2016-11-07 |
노비라 테라퓨틱스, 인코포레이티드 |
Hbv 감염의 치료를 위한 병용 요법
|
|
PT3116316T
(pt)
|
2014-03-13 |
2019-09-30 |
Assembly Biosciences Inc |
Moduladores alostéricos da proteína do núcleo da hepatite b
|
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
|
KR20160133563A
(ko)
|
2014-03-28 |
2016-11-22 |
선샤인 레이크 파르마 컴퍼니 리미티드 |
다이하이드로피리미딘 화합물 및 이의 약제학적 용도
|
|
CA2950807C
(en)
|
2014-05-30 |
2022-05-31 |
Medshine Discovery Inc. |
Dihydropyrimido fused ring derivative as hbv inhibitor
|
|
WO2016089990A1
(en)
|
2014-12-02 |
2016-06-09 |
Novira Therapeutics, Inc. |
Sulfide alkyl and pyridyl reverse sulfonamide compounds for hbv treatment
|
|
US9550779B2
(en)
|
2014-12-30 |
2017-01-24 |
Novira Therapeutics, Inc. |
Derivatives and methods of treating hepatitis B infections
|
|
MA41338B1
(fr)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Composés de pyrazine pour le traitement de maladies infectieuses
|
|
EP3271019A1
(en)
|
2015-03-19 |
2018-01-24 |
Novira Therapeutics Inc. |
Azocane and azonane derivatives and methods of treating hepatitis b infections
|
|
WO2016161268A1
(en)
|
2015-04-01 |
2016-10-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antviral agents
|
|
US10273228B2
(en)
|
2015-04-17 |
2019-04-30 |
Indiana University Research And Technology Corporation |
Hepatitis B viral assembly effectors
|
|
US10738035B2
(en)
|
2015-05-13 |
2020-08-11 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
|
KR20180129943A
(ko)
*
|
2016-04-15 |
2018-12-05 |
노비라 테라퓨틱스, 인코포레이티드 |
캡시드 조립 억제제를 포함하는 배합물 및 방법
|